DWQA Questions › Tag: National Institutes of Health
Filter:AllOpenResolvedClosedUnanswered
In 2001, the National Institutes of Health (NIH) launched a trial to lower blood glucose levels in diabetic patients to reduce their risk for heart attack, stroke, or death from cardiovascular disease. The trial, called Action to Control Cardiovascular Risk in Diabetes, or ACCORD, involved over 10,000 Type 2 diabetic patients who had either been previously diagnosed with heart disease or had two or more risk factors for heart disease when they entered the study. Half received standard treatment and half were treated aggressively with higher doses of antidiabetic drugs. The trial was halted 18 months early because of a 26% increase in deaths in the aggressively treated group. The NIH said there was no conclusive link to a particular medication. Were these outcomes just a fluke or was over-medication involved? What is Creator’s perspective?
ClosedNicola asked 2 days ago • 
10 views0 answers0 votes
Ask Question